School of Chemistry, National University of Ireland, University Road, Galway, Ireland.
Glycobiology. 2014 Jan;24(1):85-96. doi: 10.1093/glycob/cwt094. Epub 2013 Oct 16.
Protein glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of serine/threonine residues in nucleocytoplasmic proteins. O-GlcNAc has been shown to play a role in many different cellular processes and O-GlcNAcylation is often found at sites that are also known to be phosphorylated. Unlike phosphorylation, O-GlcNAc levels are regulated by only two enzymes, O-GlcNAc transferase (OGT) and O-GlcNAc hydrolase (O-GlcNAcase or OGA). So far, no obvious consensus sequence has been found for sites of O-GlcNAcylation. Additionally, O-GlcNAcase recognizes and cleaves all O-GlcNAcylated proteins, independent of their sequence. In this work, we generate and analyze five models of O-GlcNAcylated peptides in complex with a bacterial OGA. Each of the five glycopeptides bind to OGA in a similar fashion, with OGA-peptide interactions primarily, but not exclusively, involving the peptide backbone atoms, thus explaining the lack of sensitivity to peptide sequence. Nonetheless, differences in peptide sequences, particularly at the -1 to -4 positions, lead to variations in predicted affinity, consistent with observed experimental variations in enzyme kinetics. The potential exists, therefore, to employ the present analysis to guide the development glycopeptide-specific inhibitors, or conversely, the conversion of OGA into a reagent that could target specific O-GlcNAcylated peptide sequences.
蛋白质的 O-连接 N-乙酰葡萄糖胺(O-GlcNAc)糖基化是核质蛋白丝氨酸/苏氨酸残基的一种翻译后修饰。O-GlcNAc 已被证明在许多不同的细胞过程中发挥作用,并且 O-GlcNAcylation 通常发生在已知也被磷酸化的位点。与磷酸化不同,O-GlcNAc 水平仅由两种酶调节,O-GlcNAc 转移酶(OGT)和 O-GlcNAc 水解酶(O-GlcNAcase 或 OGA)。到目前为止,尚未发现 O-GlcNAcylation 位点的明显共识序列。此外,O-GlcNAcase 识别并切割所有 O-GlcNAc 化的蛋白质,而不考虑其序列。在这项工作中,我们生成并分析了与细菌 OGA 复合的五个 O-GlcNAc 化肽的模型。这五个糖肽中的每一个都以相似的方式与 OGA 结合,OGA-肽相互作用主要但不完全涉及肽骨架原子,从而解释了对肽序列缺乏敏感性。尽管如此,肽序列的差异,特别是在-1 到-4 位,导致预测亲和力的变化,与观察到的酶动力学实验变化一致。因此,有可能利用目前的分析来指导糖肽特异性抑制剂的开发,或者相反,将 OGA 转化为可以靶向特定 O-GlcNAc 化肽序列的试剂。